Literature DB >> 14639703

Reducing sample sizes in genome scans: group sequential study designs with futility stops.

Inke R König1, Helmut Schäfer, Andreas Ziegler, Hans-Helge Müller.   

Abstract

Group sequential study designs can greatly facilitate analyses of genetic linkage in complex traits. We recently proposed designs allowing stopping investigations early if the result is significant (König et al. [2001] Am. J. Hum. Genet. 69:590-600), thereby decreasing average sample sizes under the alternative hypothesis. However, average sample sizes were slightly increased under the null hypothesis. We now present designs where the analysis of markers is additionally stopped in case of futility, i.e., if the probability for significant results is sufficiently low. These sequential designs are applied to linkage analyses of single loci. We calculated sample sizes, time points, and critical boundaries for all analyses for 2- and 3-stage designs at an overall significance level of 0.0001. To confirm the validity of asymptotic approximations, Monte Carlo simulations were performed. The utility is demonstrated analyzing genome scan data provided for the Genetic Analysis Workshop 12. Application of the novel sequential designs yields tremendous decreases in average sample sizes, regardless of the size of the underlying genetic effect at investigated loci. Depending on the applied design, almost half of the sample size is spared on average. These enormous savings are expected to have a special impact on costs and time of large-scale studies such as genome scans. Copyright 2003 Wiley-Liss, Inc.

Mesh:

Year:  2003        PMID: 14639703     DOI: 10.1002/gepi.10265

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  1 in total

1.  Optimum two-stage designs in case-control association studies using false discovery rate.

Authors:  Aya Kuchiba; Noriko Y Tanaka; Yasuo Ohashi
Journal:  J Hum Genet       Date:  2006-09-27       Impact factor: 3.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.